The purview of Parkinsonism in Ayurveda

  • Dr. Shereen Sreenivas Post Graduate Scholar, Department of Kayachikitsa, Sri Kalabyraveshwaraswamy Ayurvedic Medical College, Hospital and Research Centre, Bengaluru, Karnataka, INDIA.
  • Dr. Muralidhara Professor, Sri Kalabyraveshwara Swamy Ayurvedic Medical Coleege Hospital & Research Centre, Bengaluru, Karnataka, INDIA.
  • Dr. Sindhura A. S. Lecturer, Department of Kayachikitsa, Sri Kalabyraveshwara Swamy Ayurvedic Medical Coleege Hospital & Research Centre, Bengaluru, Karnataka, INDIA.
Keywords: Parkinsonism, Baahukampavata, Snayugatavata, Kaphavruta Vyanavata, Kampavata

Abstract

Parkinsonism is a clinical syndrome in which the Parkinson’s disease accounts for 80% of involvement. Parkinson’s disease specifically refers to patients who have Parkinsonism, without any atypical features and who have essentially normal MRI that excludes other causes for their Parkinsonian symptoms.The main difference between the two are the effect of levadopa drug in Parkinson’s disease and not the other. Parkinson’s disease, which is the second most common neurodegenerative disorder after Alzheimer disease, occurs in approximately 1 in 1000 in the general population and in 1% of persons older than 65 years. Men are affected slightly more often than women (3:2). The cause of Parkinson’s disease is believed to be a variable combination of poorly understood genetic and environmental factors. Hence treatment is often aimed at prevention of further complications and preserving the condition using general measures, drug therapy and surgery. In Ayurveda, giving importance to prevention of further derangement, Lakshanika Chikitsa is often attributed to the different stages of the disease. Parkinson’s disease is generally understood as Kampavata in Ayurveda. But the development of the disease can be understood under various concepts of Bahukampavata, Snayugatavata, Kaphavruta Vyanavata and Kampavata. As Parkinsonism is widely treated with better efficacy in Ayurveda, hence it is the need of the hour to understand it in all its aspects with its relevant treatment.Hence the main aim of this article is to understand these varied concepts in possible correlation with the Parkinson’s disease.

Downloads

Download data is not yet available.

References

Nancy E. Lane Thomas J. Schnitzer, Goldman: Cecil Medicine, 23rd ed.Copyright © 2007 Saunders, An Imprint of Elsevier,Vol 2, Chapter 409, pg 2454-2461

Czech DP*, Lee J*, Correia J, Loke H, Möller E, Harley VR (2014) Transient neuroprotection by SRY upregulation in dopamine cells following injury in males. Endocrinology. Apr 7 [Epub] PMID: 24708242 (joint first author)

Cookson MR. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring HarbPerspect Med. 2012;2(9):a009415. Published 2012 Sep 1. doi:10.1101/cshperspect.a009415

Nancy E. Lane Thomas J. Schnitzer, LGoldman: Cecil Medicine, 23rd. Copyright © 2007 Saunders, An Imprint of Elsevier,Vol 2, Chapter 409, pg 2455

https://parkinsons-info.weebly.com/updrs.html

Agnivesha, Charaka Samhitta, Ayurveda Dipika commentary by Chakrapani Dutta, chaukamba orientalia, reprint 2014, chapter 28, vatavyadhichikitsa, sloka 59, pg 738, pg 619

Basavaraja, Basavarajeeyam, chaukamba samskrita pratishtana, reprint 2005, chapter 6, pg 423, pg 101

Bhavamishra, Bhava Prakasha, commentary by Dr.Bulusu Sitaram, Chaukamba Orientalia, Reprint 2014, vol 2, chapter 24, sloka 258, pg 770, pg 295

Agnivesha, Charaka Samhitta,Ayurveda Dipika commentary by Chakrapani Dutta, chaukamba orientalia, reprint 2014, chapter 28, vatavyadhichikitsa, sloka 229, pg 738, pg 626

Bhavamishra, Bhava Prakasha, commentary by Dr.Bulusu Sitaram, Chaukamba Orientalia, Reprint 2014, vol 2, chapter 24, sloka 258, pg 770, pg 294

https://www.ncbi.nlm.nih.gov/pubmed/20590830

Opara JA, Brola W, Leonardi M, Błaszczyk B. Quality of life in Parkinson's disease. J Med Life. 2012;5(4):375– 381

Agnivesha, Charaka Samhitta, Ayurveda Dipika commentary by Chakrapani Dutta, chaukamba orientalia, reprint 2014, chapter 28, vatavyadhichikitsa, sloka 75-77, pg 738, pg 620

Agnivesha, Charaka Samhitta, Ayurveda Dipika commentary by Chakrapani Dutta, chaukamba orientalia, reprint 2014, chapter 28, vatavyadhi chikitsa, sloka 238-245, pg 738, pg 627

Katzenschlager R et al. Mucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75:1677

Alleman RJ Jr et al. A blend of chlorophytum borivilianum and velvet bean increases serum growth hormone in exercise-trained men. Nutrition and Metabolic Insights. 2011;4:55-63

Obogwu MB, Akindele AJ, Adeyemi OO. Hepatoprotective and in vivo antioxidant activities of the hydroethanolic leaf extract of mucunapruriens (Fabaceae) in antitubercular drugs and alcohol models. Chinese Journal of Natural Medicines. 2014;12:273-283

Vaidya AB et al. Treatment of Parkinson's disease with the cowhage plant-mucunapruriens Bak. Neurology India. 1978;26:171-176

How to Cite
Dr. Shereen Sreenivas, Dr. Muralidhara, & Dr. Sindhura A. S. (2019). The purview of Parkinsonism in Ayurveda. Journal of Ayurveda and Integrated Medical Sciences, 4(05), 249-254. Retrieved from https://jaims.in/jaims/article/view/730
Section
Review Article